3.91 -0.03 (-0.76%)
4:00 PM ET 12/07/09
Company Profile
Price and Volume
Recent Price 3.94
52 Week High 18.75
52 Week Low 3.22
Avg. Daily Vol. (Mil) 0.76
Beta (3 year) 0.65
Share Related Items
Mkt Cap (Mil) 143.50
Shares Out (Mil) 36.42
Float (Mil) 14.97
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 3.00
Current Ratio 3.10
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 10.21
Price/Book 5.98K
Price/Cash Flow -3.70
Per Share Data
Earnings -1.35
Sales 0.39
Book Value 0.00
Cash Flow -1.08
Business Summary
A biopharmaceutical company dedicated to the discovery, development and commercialization of small molecules that selectively target hormone pathways to treat cancer, osteoporosis and bone loss, muscle loss and other serious medical conditions.
General Information
3 North Dunlap Street
Van Vleet Bldg.
Memphis, TN 38163
www.gtxinc.com
Industry : Drugs
Sector: Health Care
Employees: 147
CEO: Dr. Mitchell S. Steiner,
Short Interest
Current Month (Mil) 7.53
Previous Month (Mil) 8.38
Short Interest Ratio (Days) 5.80
Management Effectiveness
Return on Equity n.a.
Return on Assets -75.70
Return on Investments -205.00
Profitability
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00
Dow Jones S&P 500 NASDAQ 10-Year Note
10,390.11 1,103.25 2,189.61 34.48
Oil *
76.70
UP
1.21
DOWN
2.73
DOWN
4.74
DOWN
0.35
10 Yr
3.45%
SPDR Gold
113.11
+0.01%
-0.25%
-0.22%
-1.00%
Data delayed 20 minutes

Brokerage Partners

TheStreet Premium Services

All Services